PT  - JOURNAL ARTICLE
AU  - David J. Smith
AU  - Alessandro Prete
AU  - Angela E. Taylor
AU  - Niki Karavitaki
AU  - Wiebke Arlt
TI  - Modelling oral adrenal cortisol support
AID  - 10.1101/2020.05.29.20117051
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.29.20117051
4099  - http://medrxiv.org/content/early/2020/06/03/2020.05.29.20117051.short
4100  - http://medrxiv.org/content/early/2020/06/03/2020.05.29.20117051.full
AB  - A simplified mathematical model of oral hydrocortisone delivery in adrenal insufficiency is described; the model is based on three components (gastric hydrocortisone, free serum cortisol and bound serum cortisol) and is formulated in terms of linear kinetics, taking into account the dynamics of glucocorticoid–protein binding. Motivated by the need to optimise cortisol replacement in the situations of COVID-19 infection, the model is fitted to recently-published data on 50 mg dosing and earlier data on 10 mg dosing. The fitted model is used to predict typical responses to standard dosing regimes, which involve a larger dose in the morning and 1 or 2 smaller doses later in the day, and the same regimes with doses doubled. In all cases there is a circadian-like response, with early morning nadir. The model is also used to consider an alternative dosing strategy based on four equal and equally-spaced doses of 10, 20 or 30 mg per 24 h, resulting in a more even response resembling a response to sustained inflammatory stress.Competing Interest StatementThe authors have declared no competing interest.Funding StatementData were generated via the Prevention of adrenal crisis in surgery study (https://doi.org/10.1210/clinem/dgaa133), supported by Medical Research Council UK (program grant G0900567), the Oxfordshire Health Services Research Committee, and the National Institute for Health Research (NIHR) Birmingham Biomedical Research Centre at the University Hospitals Birmingham NHS Foundation Trust and the University of Birmingham (grant reference number BRC-1215-2009). AP is a Diabetes UK Sir George Alberti Research Training Fellow (grant reference number 18/0005782).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:South Birmingham REC Ref 07/H1207/22All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated during and/or analyzed during the current study are not publicly available but are available from W. Arlt (w.arlt{at}bham.ac.uk) on reasonable request